Value Aligned Research Advisors’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.8M Hold
13,500
0.02% 91
2025
Q4
$3.99M Hold
13,500
0.04% 73
2025
Q3
$3.33M Hold
13,500
0.04% 71
2025
Q2
$2.11M Buy
13,500
+5,500
+69% +$585K 0.04% 60
2025
Q1
$630K Sell
8,000
-1,600
-17% -$170K 0.05% 52
2024
Q4
$125K Buy
+9,600
New +$751K 0.03% 38
2024
Q3
Sell
-500
Closed -$3.53K 24
2024
Q2
$3.53K Buy
+500
New +$25.2K ﹤0.01% 28

Other funds holding CLS

Value Aligned Research Advisors's CLS Position: Q1 2026 in Review

Value Aligned Research Advisors increased its Celestica (CLS) stake by 30% in Q1 2026, buying an estimated $99.1M and bringing the position to 1,491,494 shares worth $420M. The position accounts for 2.03% of the portfolio, ranked #12.

Value Aligned Research Advisors first reported a position in CLS in Q2 2024 and has held it in 8 quarters since. 773 funds tracked by Wall St. Rank hold CLS as of Q1 2026.

  • Value Aligned Research Advisors held 1,491,494 shares of Celestica worth $420M as of Q1 2026.
  • Value Aligned Research Advisors bought 341,666 Celestica shares in Q1 2026, an estimated $99.1M.
  • Celestica made up 2.03% of Value Aligned Research Advisors's portfolio in Q1 2026, its #12 holding.
  • Value Aligned Research Advisors first reported a position in Celestica in Q2 2024 and has held it in 8 quarters since.
  • 773 funds tracked by Wall St. Rank held Celestica as of Q1 2026.

Based on Value Aligned Research Advisors's 13F filing for Q1 2026, filed 18 May 2026.